Lyell Immunopharma, Inc. (LYEL)
NASDAQ: LYEL · Real-Time Price · USD
0.590
+0.007 (1.22%)
Jan 31, 2025, 4:00 PM EST - Market closed
Lyell Immunopharma Market Cap
Lyell Immunopharma has a market cap or net worth of $172.46 million as of January 31, 2025. Its market cap has decreased by -65.76% in one year.
Market Cap
172.46M
Enterprise Value
-229.62M
1-Year Change
-65.76%
Ranking
Category
Stock Price
$0.59
Market Cap Chart
Since the IPO on June 17, 2021, Lyell Immunopharma's market cap has decreased from $4.13B to $172.46M, a decrease of -95.82%. That is a compound annual growth rate of -58.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 31, 2025 | 172.46M | -7.77% |
| Dec 31, 2024 | 186.98M | -61.73% |
| Dec 29, 2023 | 488.63M | -43.52% |
| Dec 30, 2022 | 865.16M | -53.52% |
| Dec 31, 2021 | 1.86B | -54.91% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 735.38B |
| UnitedHealth Group | 500.57B |
| Novo Nordisk | 375.61B |
| Johnson & Johnson | 367.70B |
| AbbVie | 328.31B |
| Merck & Co. | 250.33B |
| Thermo Fisher Scientific | 228.91B |
| Abbott Laboratories | 222.10B |